title: Activity of a novel PDGF beta-receptor enhancer during the cell cycle and upon differentiation of neuroblastoma.
abstract: PDGF acts as an autocrine and paracrine factor in certain tumors through upregulation of the PDGF beta-receptor expression. In order to elucidate the control mechanism for the receptor expression, we have isolated an enhancer from two P1 clones that together contain a 102 kb NotI region covering the entire human PDGFRB gene. They were partially digested with TspI and cloned into the PDGFRB enhancer trap vector to make a library for identification of enhancers. The digested DNA containing enhancer was identified by expression of GFP when transfected in PDGF beta-receptor expressing cells. One of the enhancer clones was further examined by making several deletion mutants in a luciferase vector. This enhancer was most active in neuroblastoma cells, IMR32 and BE2, but less active in hemangioma and in smooth muscle cell lines. Chip assay revealed that SP1, AP2, and GATA2 bound the enhancer in BE2 cells. Their interaction occurred dependently of the cell cycle and synchronously with their binding to the promoter. Transfection of GATA2 alone or with Ets, which binds adjacent to GATA, resulted in differentiation of BE2 cells in parallel with increased PDGF beta-receptor expression. Furthermore, over-expression of the PDGF beta-receptor in BE2 cells induced neurite extension.
authors.affiliation: Institute of Biomedicine, Department of Medical Chemistry and Cell Biology, Göteborg University, Box 420, SE-405 30 Gothenburg, Sweden.
authors.forename: Masaharu
authors.initials: M
authors.lastname: Kaneko
authors.forename: Weiwen
authors.initials: W
authors.lastname: Yang
authors.forename: Yoshiki
authors.initials: Y
authors.lastname: Matsumoto
authors.forename: Fujiko
authors.initials: F
authors.lastname: Watt
authors.forename: Keiko
authors.initials: K
authors.lastname: Funa
mesh_terms: D000818:Animals; D002453:Cell Cycle / Q000235:genetics*; D002454:Cell Differentiation / Q000235:genetics*; D045744:Cell Line, Tumor; D002478:Cells, Cultured; D003001:Cloning, Molecular; D004268:DNA-Binding Proteins / Q000502:physiology; D004742:Enhancer Elements, Genetic; D050989:GATA2 Transcription Factor / Q000502:physiology; D017353:Gene Deletion; D006391:Hemangioma / Q000378:metabolism / Q000473:pathology; D006801:Humans; D051379:Mice; D009130:Muscle, Smooth / Q000166:cytology / Q000378:metabolism; D009414:Nerve Growth Factors / Q000378:metabolism; D009447:Neuroblastoma / Q000378:metabolism / Q000473:pathology*; D051381:Rats; D020797:Receptor, Platelet-Derived Growth Factor beta / Q000235:genetics* / Q000378:metabolism*; D016329:Sp1 Transcription Factor / Q000502:physiology
chemical_list: D004268:DNA-Binding Proteins; D050989:GATA2 Transcription Factor; D009414:Nerve Growth Factors; D016329:Sp1 Transcription Factor; C083115:activator protein-2 binding element; D020797:Receptor, Platelet-Derived Growth Factor beta